Have a personal or library account? Click to login
The genetic landscape of early and late-onset Alzheimer’s disease: A review Cover

The genetic landscape of early and late-onset Alzheimer’s disease: A review

Open Access
|Dec 2024

References

  1. Breitner JCS. Clinical Genetics and Genetic Counseling in Alzheimer Disease. Ann Intern Med. 1991;115(8):601-606. doi:10.7326/0003-4819-601
  2. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine. 2011;13(6):597-605. doi:10.1097/ GIM.0b013e31821d69b8
  3. Barber RC. The genetics of Alzheimer’s disease. Scientifica (Cairo). 2012;2012:1-14. doi:10.6064/2012/246210
  4. Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10). doi:10.1101/cshperspect.a006296
  5. Bird TD. Genetic aspects of Alzheimer disease. Genetics in Medicine. 2008;10(4):231-239. doi:10.1097/GIM.0b013e31816b64dc
  6. Bekris LM, Yu CE, Bird TD, Tsuang DW. Review article: Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(4):213-227. doi:10.1177/0891988710383571
  7. Williamson J, Goldman J, Marder KS. Genetic aspects of alzheimer disease. Neurologist. 2009;15(2):80-86. doi:10.1097/NRL.0b013e318187e76b
  8. Carmona S, Hardy J, Guerreiro R. The genetic landscape of Alzheimer disease. In: Handbook of Clinical Neurology. Vol 148. III. Elsevier B.V.; 2018:395-408. doi:10.1016/B978-0-444-64076-5.00026-0
  9. Tudose C, Maniu M, Maniu C. GENETICĂ UMANĂ. Editura CORSON; 2000.
  10. Covic M. Curs de Genetică Medicală. Institutul de Medicină și Farmacie, Disciplina de Biologie si genetică medicală; 1981.
  11. Covic M, Stefănescu D, Sandovici I. Genetică Medicală. Editura Polirom; 2004.
  12. Covic M, Ştefănescu D, Sandovici I. Genetică Medicală. Polirom; 2017.
  13. Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference? Neurol Genet. 2020;6(5). doi:10.1212/NXG.0000000000000512
  14. Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. In: Handbook of Clinical Neurology. Vol 167. Elsevier B.V.; 2019:231-255. doi:10.1016/B978-0-12-804766-8.00013-3
  15. Scheltens P, Blennow K, Breteler MMB, et al. Alzheimer’s disease. The Lancet. 2016;388(10043):505-517. doi:10.1016/S0140-6736(15)01124-1
  16. American Psychiatric Association. DSM-5-TR.; 2022.
  17. American Psychiatric Association. DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS - FOURTH EDITION - DSM-IV-TR.; 2010.
  18. American Psychiatric Association. DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS FIFTH EDITION - DSM-5-TR. Vol V.; 2022.
  19. Morley JE, Farr SA, Nguyen AD. Alzheimer Disease. Clin Geriatr Med. 2018;34(4):591-601. doi:10.1016/j.cger.2018.06.006
  20. Turner RS. Alzheimer’s disease. Semin Neurol. 2006;26(5):499-506. doi:10.1055/s-2006-951622
  21. Tcw J, Goate AM. Genetics of β-Amyloid Precursor Protein in Alzheimer’s Disease. Cold Spring Harb Perspect Med. 2017;7(6). doi:10.1101/cshperspect.a024539
  22. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. The Lancet. 2021;397(10284):1577-1590. doi:10.1016/S0140-6736(20)32205-4
  23. Goldman JS. Predictive genetic counseling for neurodegenerative diseases: Past, present, and future. Cold Spring Harb Perspect Med. 2020;10(7):1-15. doi:10.1101/cshperspect.a036525
  24. Goldman JS. New approaches to genetic counseling and testing for alzheimer’s disease and frontotemporal degeneration. Curr Neurol Neurosci Rep. 2012;12(5):502-510. doi:10.1007/s11910-012-0296-1
  25. Calabrò M, Rinaldi C, Santoro G, Crisafulli C. The biological pathways of Alzheimer disease: a review. AIMS Neurosci. 2021;8(1):86-132. doi:10.3934/Neuroscience.2021005
  26. Nicolas G, Zaréa A, Lacour M, et al. Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening. Genetics in Medicine. 2024;26(5). doi:10.1016/j.gim.2024.101082
  27. Pavarini G, Hamdi L, Lorimer J, Singh I. Young people’s moral attitudes and motivations towards direct-to-consumer genetic testing for inherited risk of Alzheimer disease. Eur J Med Genet. 2021;64(6). doi:10.1016/j.ejmg.2021.104180
  28. Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1). doi:10.1038/s41572-021-00269-y
  29. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s and Dementia. 2011;7(3):263-269. doi:10.1016/j.jalz.2011.03.005
  30. Rademakers R, Dermaut B, Peeters K, et al. Tau (MAPT) muta tion Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe. Hum Mutat. 2003;22:409-411.
  31. Rademakers R, Corsmit E, Cruts M, et al. Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am J Hum Genet. 2005;77:643-652.
  32. Ostojic J, Elfgren C, Passant U, et al. The tau R406Wmuta tion causes progressive presenile dementiawithbitempo ral atrophy. Dement Geriatr Cogn Disord. 2004;17:298-301.
  33. Frigerio C, Piscopo P, Calabrese E, et al. PEN-2 gene mutation in a familial Alzheimer’s disease case. J Neurol . 2005;252:1033-1036.
  34. Bennett DA, Yu L, Yang J, Klein HU, De Jager PL. Epigenomics of Alzheimer’s Disease. In: Epigenomics of Alzheimer’s Disease. Elsevier Inc.; 2017:227-278. doi:10.1016/B978-0-12-800802-7.00009-5
  35. Bird TD. Alzheimer Disease Overview. GeneReviews. Published online 1998:1993-2023.
  36. Blasco D, Roberts JS. Implications of Emerging Uses of Genetic Testing for Alzheimer’s Disease. Journal of Prevention of Alzheimer’s Disease. 2023;10(3):359-361. doi:10.14283/jpad.2023.46
  37. Di Fede G, Catania M, Morbin M, et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science (1979). 2009;323(5920):1473-1477. doi:10.1126/science.1168979
  38. Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541-5554. doi:10.2147/IJN.S200490
  39. Hutton M, Hardy J. The presenilins and Alzheimer’s disease. Hum Mol Genet. 1997;6(10):1639-1646.
  40. Rosenberg RN, Lambracht-Washington D, Yu G, Xia W. Genomics of Alzheimer disease: A review. JAMA Neurol. 2016;73(7):867-874. doi:10.1001/jamaneurol.2016.0301
  41. Mahley RW, Rall SC. APOLIPOPROTEIN E: Far More Than a Lipid Transport Protein. Annu Rev Genomics Hum Genet. 2000;1(1):507-537. doi:10.1146/annurev.genom.1.1.507
DOI: https://doi.org/10.2478/amma-2024-0030 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 205 - 215
Submitted on: Aug 30, 2024
|
Accepted on: Sep 24, 2024
|
Published on: Dec 24, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Paula Denisa Saragea, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.